跳至主要内容
临床试验/CTRI/2024/08/071952
CTRI/2024/08/071952尚未招募不适用

Association of APRI,FIB-4,AST/ALT with Fibroscan in Patients of Non Alcoholic Fatty Liver Disease for assesing Hepatic Fibrosis

Department of general medicine1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2024年8月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
113
试验地点
1
主要终点
Find out association of APRI,FIB-4,AST/ALT ration with fibroscan and using it for assessing hepatic fibrosis

研究概览

简要总结

The study will recruit the patients of NAFLD who have underwent fibroscan and cbc,Lft in the a duration of one month both from op and IP of general medicine and medical gastroenterology

And APRI,FIB-4,AST/ALT ratio will be calculated and is used to find association with fibroscan in assessing hepatic fibrosis

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients who are diagnosed having NAFLD and NASH , undergoing fibrous scan in kasturba hospital Manipal.

排除标准

  • Hepatitis B, hepatitis C, auto immune hepatitis, ITP ,history of herbal medication use, history of inherited jaundice.

结局指标

主要结局

Find out association of APRI,FIB-4,AST/ALT ration with fibroscan and using it for assessing hepatic fibrosis

时间窗: Cross sectional study

次要结局

  • To find which score among these have better association with fibroscan(Cross sectional study)

研究者

发起方
Department of general medicine
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

DR.Nannaka Vikas

Kasturba Medical College and Hospital manipal

研究点 (1)

Loading locations...

相似试验